TABLE OF CONTENTS As filed with the United States Securities and Exchange Commission on January 29, 2026. Registration Statement No. 333-292790 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AgomAb Therapeutics NV (Exact name of registrant as specified in its charter) 2836 (Primary Standard Industrial Classification Code Number) N/A (I.R.S. Employer Identification Number) (State or Other Jurisdiction ...

TABLE OF CONTENTS As filed with the United States Securities and Exchange Commission on January 16, 2026. Registration Statement No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AgomAb Therapeutics NV (Exact name of registrant as specified in its charter) 2836 (Primary Standard Industrial Classification Code Number) N/A (I.R.S. Employer Identification Number) Posthoflei 1/6 2600 Antwerpen, Belgium Tel: +32 3 318 ...